Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Epilepsy

  Free Subscription


Articles published in Brain Dev

Retrieve available abstracts of 57 articles:
HTML format



Single Articles


    November 2022
  1. OHTA K, Okanishi T, Kanai S, Nakamura Y, et al
    Stimulus-induced focal motor seizure in a pediatric patient with carbamazepine overdose.
    Brain Dev. 2022;44:765-768.
    PubMed     Abstract available


    October 2022
  2. UEMATSU K, Matsumoto H, Zaha K, Mizuguchi M, et al
    Prediction and assessment of acute encephalopathy syndromes immediately after febrile status epilepticus.
    Brain Dev. 2022 Oct 31. pii: S0387-7604(22)00172.
    PubMed     Abstract available


  3. HU Q, Luo Y, Li T, Ma J, et al
    Early-onset spontaneously relieved spasms of infancy in sleep: Electroclinical characteristics and differential diagnoses.
    Brain Dev. 2022;44:612-617.
    PubMed     Abstract available


    September 2022
  4. SAGER SG, Turkyilmaz A, Gunbey HP, Karatoprak EY, et al
    A novel de novo TET3 loss-of-function variant in a Turkish boy presenting with neurodevelopmental delay and electrical status epilepticus during slow-wave sleep.
    Brain Dev. 2022 Sep 30. pii: S0387-7604(22)00163.
    PubMed     Abstract available


  5. SUNAGA Y, Takayama Y, Yokosako S, Mizuno T, et al
    Drug-resistant temporal lobe epilepsy due to middle fossa meningoencephalocele in a child: A surgical case report.
    Brain Dev. 2022 Sep 14. pii: S0387-7604(22)00158.
    PubMed     Abstract available


  6. MORIYAMA K, Mizuno T, Suzuki T, Inaji M, et al
    ATP1A3-related early childhood onset developmental and epileptic encephalopathy responding to corpus callosotomy: A case report.
    Brain Dev. 2022 Sep 13. pii: S0387-7604(22)00159.
    PubMed     Abstract available


  7. HASHIMOTO K, Baba S, Nakagawa E, Sumitomo N, et al
    Long-term changes in electroencephalogram findings in a girl with a nonsense SMC1A variant: A case report.
    Brain Dev. 2022;44:551-557.
    PubMed     Abstract available


  8. TAKEDA Y, Sakakibara T, Ogiwara K, Nogami K, et al
    Blood coagulation dynamics during adrenocorticotropic hormone therapy in pediatric patients with infantile spasms.
    Brain Dev. 2022;44:546-550.
    PubMed     Abstract available


    August 2022
  9. SAITO M, Murai T, Motobayashi M, Ono S, et al
    Refractory status epilepticus with fever due to mumps vaccine-induced encephalitis caused secondary encephalopathy mimicking acute encephalopathy with biphasic seizures and late reduced diffusion.
    Brain Dev. 2022 Aug 24. pii: S0387-7604(22)00153.
    PubMed     Abstract available


  10. GIACOMINI T, Scala M, Nobile G, Severino M, et al
    De novo POLR2A p.(Ile457Thr) variant associated with early-onset encephalopathy and cerebellar atrophy: expanding the phenotypic spectrum.
    Brain Dev. 2022;44:480-485.
    PubMed     Abstract available


  11. D'ONOFRIO G, Riva A, Di Rosa G, Cali' E, et al
    Paroxysmal limb dystonias associated with GABBR2 pathogenic variant: A case-based literature review.
    Brain Dev. 2022;44:469-473.
    PubMed     Abstract available


  12. KOMATSU K, Fukumura S, Minagawa K, Nakashima M, et al
    A new case of concurrent existence of PRRT2-associated paroxysmal movement disorders with c.649dup variant and 16p11.2 microdeletion syndrome.
    Brain Dev. 2022;44:474-479.
    PubMed     Abstract available


    July 2022
  13. SAKATA Y, Nakamura T, Matsuo M
    Reply: Amnestic aphasia in MELAS can be epileptogenic.
    Brain Dev. 2022 Jul 7. pii: S0387-7604(22)00109.
    PubMed    


    June 2022
  14. FINSTERER J
    Amnestic aphasia in MELAS can be epileptogenic.
    Brain Dev. 2022 Jun 14. pii: S0387-7604(22)00101.
    PubMed    


  15. FUKUOKA M, Kuki I, Hattori Y, Tsuji H, et al
    A case of focal cortical dysplasia type IIa with pathologically suspected bilateral Rasmussen syndrome.
    Brain Dev. 2022;44:401-404.
    PubMed     Abstract available


  16. KAWAKAMI S, Kubota M, Terashima H, Nagata C, et al
    Differentiating early clinical features of Panayiotopoulos syndrome from acute encephalopathy.
    Brain Dev. 2022;44:386-390.
    PubMed     Abstract available


    April 2022
  17. IIMURA Y, Nakazawa M, Suzuki H, Mitsuhashi T, et al
    Surgery for intractable epilepsy after severe encephalopathy with reversible splenial lesion and new onset hippocampal lesion associated with parechovirus.
    Brain Dev. 2022 Apr 4. pii: S0387-7604(22)00049.
    PubMed     Abstract available


    March 2022
  18. OHNO A, Okumura A, Fukasawa T, Nakata T, et al
    Acute encephalopathy with biphasic seizures and late reduced diffusion: Predictive EEG findings.
    Brain Dev. 2022;44:221-228.
    PubMed     Abstract available


    February 2022
  19. OKANISHI T, Fujii Y, Sakuma S, Shiraishi H, et al
    Lacosamide monotherapy for the treatment of childhood epilepsy with centrotemporal spikes.
    Brain Dev. 2022 Feb 28. pii: S0387-7604(22)00024.
    PubMed     Abstract available


  20. SAKATA Y, Sano K, Aoki S, Saitsu H, et al
    Neurochemistry evaluated by MR spectroscopy in a patient with SPTAN1-related developmental and epileptic encephalopathy.
    Brain Dev. 2022 Feb 23. pii: S0387-7604(22)00020.
    PubMed     Abstract available


  21. KIKUCHI K, Hamano SI, Matsuura R, Nonoyama H, et al
    The effectiveness of intravenous benzodiazepine for status epilepticus in Dravet syndrome.
    Brain Dev. 2022 Feb 1. pii: S0387-7604(22)00006.
    PubMed     Abstract available


  22. JHA R, Kurup A, Kovilapu UB, Ranjan R, et al
    Somatic mutations involving TSC 1 and TSC2 genes in two children with focal cortical dysplasia.
    Brain Dev. 2022;44:166-172.
    PubMed     Abstract available


  23. GRABER D, Imagawa E, Miyake N, Matsumoto N, et al
    Polymicrogyria in a child with KCNMA1-related channelopathy.
    Brain Dev. 2022;44:173-177.
    PubMed     Abstract available


  24. MATSUURA R, Hamano SI, Daida A, Horiguchi A, et al
    Serum matrix metallopeptidase-9 and tissue inhibitor of metalloproteinase-1 levels may predict response to adrenocorticotropic hormone therapy in patients with infantile spasms.
    Brain Dev. 2022;44:114-121.
    PubMed     Abstract available


    January 2022
  25. TAHARA M, Higurashi N, Narita A, Ida H, et al
    Long-term efficacy of low-dose perampanel for progressive myoclonus epilepsy in a patient with Gaucher disease type 3.
    Brain Dev. 2022 Jan 3. pii: S0387-7604(21)00230.
    PubMed     Abstract available


  26. HADI DA, Mohamed AR, Rethanavelu K, Khoo TB, et al
    Clonic seizures, continuous spikes-and-waves during slow sleep, choreoathetosis and response to sulthiame in a child with FRRS1L encephalopathy.
    Brain Dev. 2022;44:44-49.
    PubMed     Abstract available


    December 2021
  27. CHEN J, Liu P, Hu W, Shi K, et al
    Absence seizures during sleep in childhood absence epilepsy: A sign of drug resistance?
    Brain Dev. 2021 Dec 9. pii: S0387-7604(21)00213.
    PubMed     Abstract available


    November 2021
  28. CHAN DL, Rudinger-Thirion J, Frugier M, Riley LG, et al
    A case of QARS1 associated epileptic encephalopathy and review of epilepsy in aminoacyl-tRNA synthetase disorders.
    Brain Dev. 2021 Nov 10. pii: S0387-7604(21)00203.
    PubMed     Abstract available


  29. NAKAMURA Y, Okanishi T, Yamada H, Okazaki T, et al
    Progressive cerebral atrophies in three children with COL4A1 mutations.
    Brain Dev. 2021;43:1033-1038.
    PubMed     Abstract available


  30. BOUHADOUN S, Poulin C, Berrahmoune S, Myers KA, et al
    A retrospective analysis of memantine use in a pediatric neurology clinic.
    Brain Dev. 2021;43:997-1003.
    PubMed     Abstract available


    October 2021
  31. YAMAGUCHI H, Nishiyama M, Tomioka K, Hongo H, et al
    Growth and differentiation factor-15 as a potential prognostic biomarker for status-epilepticus-associated-with-fever: A pilot study.
    Brain Dev. 2021 Oct 27. pii: S0387-7604(21)00187.
    PubMed     Abstract available


  32. ONO-TAKIGUCHI Y, Muramatsu K, Koshu K, Yamagata T, et al
    Forced normalization of Lennox-Gastaut syndrome using lacosamide: A case report.
    Brain Dev. 2021;43:963-966.
    PubMed     Abstract available


    September 2021
  33. KIRIKAE H, Uematsu M, Numata-Uematsu Y, Saijo N, et al
    Two types of early epileptic encephalopathy in a Pitt-Hopkins syndrome patient with a novel TCF4 mutation.
    Brain Dev. 2021 Sep 24. pii: S0387-7604(21)00174.
    PubMed     Abstract available


  34. TAKAMI Y, Nakagawa T
    Risk of seizure recurrence after a first unprovoked seizure in childhood.
    Brain Dev. 2021;43:843-850.
    PubMed     Abstract available


    August 2021
  35. KASHIKI T, Kido J, Momosaki K, Kusunoki S, et al
    Mitochondrial DNA depletion syndrome with a mutation in SLC25A4 developing epileptic encephalopathy: A case report.
    Brain Dev. 2021 Aug 25. pii: S0387-7604(21)00155.
    PubMed     Abstract available


  36. ICHINOSE F, Nakamura T, Kira R, Furuno K, et al
    Incidence and risk factors of acute encephalopathy with biphasic seizures in febrile status epilepticus.
    Brain Dev. 2021 Aug 3. pii: S0387-7604(21)00132.
    PubMed     Abstract available


    July 2021
  37. TAIRA R, Yamamura K, Maeda T, Sakata A, et al
    Paroxysmal sympathetic hyperactivity and the later development of epilepsy in a chemotherapy-associated brain damage.
    Brain Dev. 2021 Jul 20. pii: S0387-7604(21)00129.
    PubMed     Abstract available


  38. COHEN H, Kramer U, Hausman-Kedem M, Uliel-Siboni S, et al
    Dosage of cannabidiol-enriched cannabis in children and adults with epilepsy.
    Brain Dev. 2021 Jul 2. pii: S0387-7604(21)00124.
    PubMed    


    June 2021
  39. CHEN W, Qin J, Shen Y, Liang J, et al
    Next generation sequencing in children with unexplained epilepsy: A retrospective cohort study.
    Brain Dev. 2021 Jun 10. pii: S0387-7604(21)00103.
    PubMed     Abstract available


  40. MATSUMOTO A, Kojima K, Miya F, Miyauchi A, et al
    Two cases of DYNC1H1 mutations with intractable epilepsy.
    Brain Dev. 2021 Jun 3. pii: S0387-7604(21)00094.
    PubMed     Abstract available


  41. AZUMAGAWA K, Nakashima I, Kaneko K, Torisu H, et al
    A nation-wide survey of Japanese pediatric MOG antibody-associated diseases.
    Brain Dev. 2021;43:705-713.
    PubMed     Abstract available


    May 2021
  42. HIRATA K, Sugawara Y, Hoshino A, Takeda S, et al
    Nonconvulsive status epilepticus following rotavirus gastroenteritis in two pediatric patients.
    Brain Dev. 2021 May 29. pii: S0387-7604(21)00098.
    PubMed     Abstract available


  43. OKA M, Kobayashi K, Shibata T, Tsuchiya H, et al
    A study on the relationship between non-epileptic fast (40 - 200 Hz) oscillations in scalp EEG and development in children.
    Brain Dev. 2021 May 26. pii: S0387-7604(21)00091.
    PubMed     Abstract available


  44. TIAN Q, Li H, Shu L, Wang H, et al
    Effective treatments for FGF12-related early-onset epileptic encephalopathies patients.
    Brain Dev. 2021 May 18. pii: S0387-7604(21)00088.
    PubMed     Abstract available


  45. ZHANG Y, Ichinose F, Maeda T, Nakamura T, et al
    A pediatric case of transient periictal MRI abnormalities after repeated seizures.
    Brain Dev. 2021 May 3. pii: S0387-7604(21)00066.
    PubMed     Abstract available


  46. SUZUKI Y, Ito S, Otani Y, Nishikawa A, et al
    Unexpected elevation in valproic acid concentration and agranulocytosis in a patient with short-chain acyl-CoA dehydrogenase deficiency.
    Brain Dev. 2021;43:657-660.
    PubMed     Abstract available


  47. IZUMI T, Aihara Y, Kikuchi A, Kure S, et al
    Electroencephalographic findings and genetic characterization of two brothers with IQSEC2 pathogenic variant.
    Brain Dev. 2021;43:652-656.
    PubMed     Abstract available


  48. YAMAMOTO N, Kuki I, Nagase S, Inoue T, et al
    A case of infantile Tay-Sachs disease with late onset spasms.
    Brain Dev. 2021;43:661-665.
    PubMed     Abstract available


    April 2021
  49. KASRADZE S, Lomidze G, Cross JH, Kvernadze D, et al
    A six-year longitudinal study of neurocognitive problems in children with epilepsy.
    Brain Dev. 2021 Apr 20. pii: S0387-7604(21)00064.
    PubMed     Abstract available


  50. OGUNI H, Ito S, Nishikawa A, Otani Y, et al
    Morphometric analysis of spike-wave complexes (SWCs) causing myoclonic seizures in children with idiopathic myoclonic epilepsies - A positive SWC component correlates with myoclonic intensity.
    Brain Dev. 2021 Apr 16. pii: S0387-7604(21)00058.
    PubMed     Abstract available


  51. NEGISHI Y, Aoki Y, Itomi K, Yasuda K, et al
    SCN8A-related developmental and epileptic encephalopathy with ictal asystole requiring cardiac pacemaker implantation.
    Brain Dev. 2021 Apr 4. pii: S0387-7604(21)00061.
    PubMed     Abstract available


    March 2021
  52. BATTAGLIA D, Chieffo D, Lucibello S, Marini C, et al
    Multicenter prospective longitudinal study in 34 patients with Dravet syndrome: Neuropsychological development in the first six years of life.
    Brain Dev. 2021;43:419-430.
    PubMed     Abstract available


  53. KANATANI M, Adachi T, Sakata R, Nishimura Y, et al
    Dravet syndrome with parkinsonian symptoms and intact dopaminergic neurons: A case report.
    Brain Dev. 2021;43:486-489.
    PubMed     Abstract available


    February 2021
  54. BAMBORSCHKE D, Kreutzer M, Koy A, Koerber F, et al
    PNPT1 mutations may cause Aicardi-Goutieres-Syndrome.
    Brain Dev. 2021;43:320-324.
    PubMed     Abstract available


  55. GEIER DA, Geier MR
    A longitudinal cohort study of childhood MMR vaccination and seizure disorder among American children.
    Brain Dev. 2021;43:251-267.
    PubMed     Abstract available


  56. YOO S, Kim YA, Yoon JY, Seo GH, et al
    The first Korean cases of combined oxidative phosphorylation deficiency 35 with two novel TRIT1 mutations in two siblings confirmed by clinical and molecular investigation.
    Brain Dev. 2021;43:325-330.
    PubMed     Abstract available


  57. KIM HJ, Yang D, Kim SH, Won D, et al
    Clinical characteristics of KCNQ2 encephalopathy.
    Brain Dev. 2021;43:244-250.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Epilepsy is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: